GlobeNewswire Inc.··NaSitryx to Showcase Autoimmune Pipeline at Four Major Biopharma Conferences in April
Clinical-stage biotech Sitryx Therapeutics will present at four investor conferences in April 2026, highlighting its oral autoimmune and inflammatory disease therapies.
LLYGSKoral therapyinvestor conference